User profiles for J. A. Wedzicha
Jadwiga WedzichaNational Heart and Lung Institute, Imperial College London Verified email at imperial.ac.uk Cited by 77714 |
Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019
…, R Stockley, J Vestbo, JA Wedzicha… - European …, 2019 - Eur Respiratory Soc
Precision medicine is a patient-specific approach that integrates all relevant clinical, genetic
and biological information in order to optimise the therapeutic benefit relative to the …
and biological information in order to optimise the therapeutic benefit relative to the …
[HTML][HTML] COPD exacerbations: defining their cause and prevention
JA Wedzicha, TAR Seemungal - The lancet, 2007 - thelancet.com
Exacerbations of chronic obstructive pulmonary disease (COPD) are episodes of worsening
of symptoms, leading to substantial morbidity and mortality. COPD exacerbations are …
of symptoms, leading to substantial morbidity and mortality. COPD exacerbations are …
Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic …
JV Lightowler, JA Wedzicha, MW Elliott, FSF Ram - Bmj, 2003 - bmj.com
Objectives: To determine the effectiveness of non-invasive positive pressure ventilation (NPPV)
in the management of respiratory failure secondary to acute exacerbation of chronic …
in the management of respiratory failure secondary to acute exacerbation of chronic …
Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary
…, R Stockley, J Vestbo, JA Wedzicha… - American journal of …, 2017 - atsjournals.org
This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention
of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report …
of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report …
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease
…, R Garrod, R Garnham, PW Jones, JA Wedzicha - Thorax, 1999 - thorax.bmj.com
BACKGROUND Methods of classifying chronic obstructive pulmonary disease (COPD)
depend largely upon spirometric measurements but disability is only weakly related to …
depend largely upon spirometric measurements but disability is only weakly related to …
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease
…, TAR Seemungal, A Bhowmik, JA Wedzicha - Thorax, 2002 - thorax.bmj.com
Background: Chronic obstructive pulmonary disease (COPD) is characterised by both an
accelerated decline in lung function and periods of acute deterioration in symptoms termed …
accelerated decline in lung function and periods of acute deterioration in symptoms termed …
Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease
…, JC Bestall, DJ Jeffries, JA Wedzicha - American journal of …, 1998 - atsjournals.org
… Meecham Jones, DJ, EA Paul, PW Jones, and JA WedzichaNasal pressure support … JA
Wedzicha, Academic Department of Respiratory Medicine, The London Chest Hospital, …
Wedzicha, Academic Department of Respiratory Medicine, The London Chest Hospital, …
Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease
…, A Bhowmik, DJ Jeffries, JA Wedzicha - American journal of …, 2000 - atsjournals.org
Although exacerbations of chronic obstructive pulmonary disease (COPD) are associated
with symptomatic and physiological deterioration, little is known of the time course and …
with symptomatic and physiological deterioration, little is known of the time course and …
Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease
…, EA Paul, MW Elliott, RC Godfrey, JA Wedzicha… - The Lancet, 1993 - Elsevier
Acute exacerbations of chronic obstructive airways disease (COAD) are a common cause of
admission to hospital, and have a high mortality. Nasal intermittent positive pressure …
admission to hospital, and have a high mortality. Nasal intermittent positive pressure …
Outcomes for COPD pharmacological trials: from lung function to biomarkers
…, R Stockley, SD Sullivan, JA Wedzicha… - European respiratory …, 2008 - Eur Respiratory Soc
The American Thoracic Society/European Respiratory Society jointly created a Task Force
on “Outcomes for COPD pharmacological trials: from lung function to biomarkers” to inform …
on “Outcomes for COPD pharmacological trials: from lung function to biomarkers” to inform …